These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8584558)

  • 1. Self assembling nanostructures for sustained ophthalmic drug delivery.
    Khopade AJ; Jain NK
    Pharmazie; 1995 Dec; 50(12):812-4. PubMed ID: 8584558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of reconstitutable suspensions containing diclofenac sodium-loaded microspheres for pediatric delivery.
    Oz UC; Devrim B; Bozkır A; Canefe K
    J Microencapsul; 2015; 32(4):317-28. PubMed ID: 26154114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diclofenac-loaded Eudragit S100 nanosuspension for ophthalmic delivery.
    Ahuja M; Dhake AS; Sharma SK; Majumdar DK
    J Microencapsul; 2011; 28(1):37-45. PubMed ID: 21171815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis.
    Ramasamy T; Ruttala HB; Shanmugam S; Umadevi SK
    Drug Deliv; 2013 Feb; 20(2):65-77. PubMed ID: 23537465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.
    Pignatello R; Bucolo C; Ferrara P; Maltese A; Puleo A; Puglisi G
    Eur J Pharm Sci; 2002 Jul; 16(1-2):53-61. PubMed ID: 12113891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of diclofenac from novel Eudragit entrapped microspheres.
    Momoh MA; Kenechukwu FC; Adedokun MO; Odo CE; Attama AA
    Drug Deliv; 2014 May; 21(3):193-203. PubMed ID: 24171400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eudragit matrices for sustained release of ketorolac tromethamine: formulation and kinetics of release.
    Ruckmani K; Muneera MS; Vijaya R
    Boll Chim Farm; 2000; 139(5):205-8. PubMed ID: 11213438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrospun diclofenac sodium loaded Eudragit® L 100-55 nanofibers for colon-targeted drug delivery.
    Shen X; Yu D; Zhu L; Branford-White C; White K; Chatterton NP
    Int J Pharm; 2011 Apr; 408(1-2):200-7. PubMed ID: 21291969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
    Rawat M; Saraf S; Saraf S
    AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The physical and chemical stability of suspensions of sustained-release diclofenac microspheres.
    Lewis L; Boni RL; Adeyeye CM
    J Microencapsul; 1998; 15(5):555-67. PubMed ID: 9743912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of emulsifier blend on the characteristics of sustained release diclofenac microspheres.
    Lewis L; Boni R; Adeyeye CM
    J Microencapsul; 1998; 15(3):283-98. PubMed ID: 9608393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and evaluation of chitosan microspheres of aceclofenac for colon-targeted drug delivery.
    Umadevi SK; Thiruganesh R; Suresh S; Reddy KB
    Biopharm Drug Dispos; 2010 Oct; 31(7):407-27. PubMed ID: 20848388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation optimization of double emulsification method for preparation of enzyme-loaded Eudragit S100 microspheres.
    Rawat M; Saraf S
    J Microencapsul; 2009 Jun; 26(4):306-14. PubMed ID: 18686142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro studies of enteric coated diclofenac sodium-carboxymethylcellulose microspheres.
    Arica B; Arica MY; Kaş HS; Hincal AA; Hasirci V
    J Microencapsul; 1996; 13(6):689-99. PubMed ID: 8933354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of reconstitutable suspensions containing ibuprofen-loaded Eudragit microspheres.
    Devrim B; Bozkir A; Canefe K
    Acta Pol Pharm; 2011; 68(4):593-9. PubMed ID: 21796942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonically controlled release and targeted delivery of diclofenac sodium via gelatin magnetic microspheres.
    Saravanan M; Bhaskar K; Maharajan G; Pillai KS
    Int J Pharm; 2004 Sep; 283(1-2):71-82. PubMed ID: 15363503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
    Katara R; Majumdar DK
    Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis.
    Adibkia K; Siahi Shadbad MR; Nokhodchi A; Javadzedeh A; Barzegar-Jalali M; Barar J; Mohammadi G; Omidi Y
    J Drug Target; 2007 Jul; 15(6):407-16. PubMed ID: 17613659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of gelatin microspheres loaded with diclofenac sodium for intra-articular administration.
    Saravanan M; Bhaskar K; Maharajan G; Pillai KS
    J Drug Target; 2011 Feb; 19(2):96-103. PubMed ID: 20380621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes.
    Fujisawa T; Miyai H; Hironaka K; Tsukamoto T; Tahara K; Tozuka Y; Ito M; Takeuchi H
    Int J Pharm; 2012 Oct; 436(1-2):564-7. PubMed ID: 22828072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.